PubRank

Liise-Anne Pirofski

Author PubWeight™ 23.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A new synthesis for antibody-mediated immunity. Nat Immunol 2011 1.24
2 Microbial virulence as an emergent property: consequences and opportunities. PLoS Pathog 2011 1.16
3 The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol 2010 1.15
4 Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe 2012 1.07
5 A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice. Infect Immun 2005 1.07
6 Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan. Clin Diagn Lab Immunol 2003 1.05
7 Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide. Infect Immun 2005 1.02
8 IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status. J Infect Dis 2009 1.01
9 The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model. Respir Res 2007 1.00
10 Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice. Infect Immun 2009 0.99
11 Virulence factors and their mechanisms of action: the view from a damage-response framework. J Water Health 2009 0.97
12 Designed reduction of Streptococcus pneumoniae pathogenicity via synthetic changes in virulence factor codon-pair bias. J Infect Dis 2011 0.96
13 A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice. Infect Immun 2012 0.94
14 Feasibility and prospects for a vaccine to prevent cryptococcosis. Med Mycol 2005 0.91
15 Exploiting the redundancy in the immune system: vaccines can mediate protection by eliciting 'unnatural' immunity. J Exp Med 2003 0.91
16 Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection. J Immunol 2012 0.91
17 Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans. Clin Diagn Lab Immunol 2005 0.88
18 The weapon potential of human pathogenic fungi. Med Mycol 2006 0.88
19 Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo. Clin Vaccine Immunol 2010 0.87
20 Polysaccharide-containing conjugate vaccines for fungal diseases. Trends Mol Med 2005 0.86
21 Host immunity to Cryptococcus neoformans. Future Microbiol 2015 0.85
22 Improved survival of mice deficient in secretory immunoglobulin M following systemic infection with Cryptococcus neoformans. Infect Immun 2009 0.82
23 Exserohilum rostratum fungal meningitis associated with methylprednisolone injections. Future Microbiol 2013 0.81
24 Vaccines for the prevention of diseases caused by potential bioweapons. Clin Immunol 2004 0.81
25 Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan. Vaccine 2004 0.79